TEVA PHARMACEUTICAL INDUSTRIES LTD.

Company Overview

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company offering generic medicines, innovative medicines, biopharmaceuticals, OTC products, and APIs. The company operates in three business segments: North America, Europe, and International Markets. Each business segment manages its entire product portfolio in its region, including generics and innovative medicines. In addition to these three business segments, the company has other activities, primarily the sale of API to third parties, certain contract manufacturing services, and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Financial Highlights (FY 2024)

Company's Business Segments

• Sale of Goods : Includes lenalidomide capsules (the generic version of Revlimid), epinephrine injectable solution (the generic equivalent of EpiPen and EpiPen Jr), Truxima (the biosimilar to Rituxan) and albuterol sulfate inhalation aerosol (our ProAir authorized generic) and many other goods.
• Licensing Arrangements : Licensing arrangements performance obligations generally include intellectual property rights, certain R&D and contract manufacturing services.
• Distribution : Distribution revenues are derived from sales of third-party products for which the Company acts as distributor.
• Other : Other revenues are primarily comprised of contract manufacturing services, sales of IP rights, sales of medical devices and other miscellaneous items.